{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:49:44Z","timestamp":1792784984470,"version":"4.5.0"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,8,13]],"date-time":"2020-08-13T00:00:00Z","timestamp":1597276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,8,13]],"date-time":"2020-08-13T00:00:00Z","timestamp":1597276800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Bluefield Foundation"},{"DOI":"10.13039\/100012513","name":"Coins for Alzheimer\u2019s Research Trust","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100012513","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["AG051390"],"award-info":[{"award-number":["AG051390"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Patients with frontotemporal dementia (FTD) resulting from granulin (\n                    <jats:italic>GRN)<\/jats:italic>\n                    haploinsufficiency have reduced levels of progranulin and exhibit dysregulation in inflammatory and lysosomal networks. Microglia produce high levels of progranulin, and reduction of progranulin in microglia alone is sufficient to recapitulate inflammation, lysosomal dysfunction, and hyperproliferation in a cell-autonomous manner. Therefore, targeting microglial dysfunction caused by progranulin insufficiency represents a potential therapeutic strategy to manage neurodegeneration in FTD. Limitations of current progranulin-enhancing strategies necessitate the discovery of new targets. To identify compounds that can reverse microglial defects in\n                    <jats:italic>Grn<\/jats:italic>\n                    -deficient mouse microglia, we performed a compound screen coupled with high throughput sequencing to assess key transcriptional changes in inflammatory and lysosomal pathways. Positive hits from this initial screen were then further narrowed down based on their ability to rescue cathepsin activity, a critical biochemical readout of lysosomal capacity. The screen identified nor-binaltorphimine dihydrochloride (\n                    <jats:italic>nor<\/jats:italic>\n                    -BNI) and dibutyryl-cAMP, sodium salt (DB-cAMP) as two phenotypic modulators of progranulin deficiency. In addition,\n                    <jats:italic>nor<\/jats:italic>\n                    -BNI and DB-cAMP also rescued cell cycle abnormalities in progranulin-deficient cells. These data highlight the potential of a transcription-based platform for drug screening, and advance two novel lead compounds for FTD.\n                  <\/jats:p>","DOI":"10.1038\/s41598-020-70534-9","type":"journal-article","created":{"date-parts":[[2020,8,13]],"date-time":"2020-08-13T06:05:13Z","timestamp":1597298713000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Discovery of small molecules that normalize the transcriptome and enhance cysteine cathepsin activity in progranulin-deficient microglia"],"prefix":"10.1038","volume":"10","author":[{"given":"Maria A.","family":"Telpoukhovskaia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faten A.","family":"Sayed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon Iker","family":"Etchegaray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihong","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaqiao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yungui","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Le","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben A.","family":"Bahr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Bogyo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Gan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,8,13]]},"reference":[{"key":"70534_CR1","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1038\/nature05016","volume":"442","author":"M Baker","year":"2006","unstructured":"Baker, M. et al. Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17. Nature442, 916\u2013919. https:\/\/doi.org\/10.1038\/nature05016 (2006).","journal-title":"Nature"},{"key":"70534_CR2","doi-asserted-by":"publisher","first-page":"3931","DOI":"10.1002\/cne.22430","volume":"518","author":"TL Petkau","year":"2010","unstructured":"Petkau, T. L. et al. Progranulin expression in the developing and adult murine brain. J. Comp. Neurol.518, 3931\u20133947. https:\/\/doi.org\/10.1002\/cne.22430 (2010).","journal-title":"J. Comp. Neurol."},{"key":"70534_CR3","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1038\/nature05017","volume":"442","author":"M Cruts","year":"2006","unstructured":"Cruts, M. et al. Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21. Nature442, 920\u2013924. https:\/\/doi.org\/10.1038\/nature05017 (2006).","journal-title":"Nature"},{"key":"70534_CR4","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1192\/bjp.180.2.140","volume":"180","author":"JS Snowden","year":"2002","unstructured":"Snowden, J. S., Neary, D. & Mann, D. M. A. Frontotemporal dementia. Br. J. Psychiatry180, 140\u2013143. https:\/\/doi.org\/10.1192\/bjp.180.2.140 (2002).","journal-title":"Br. J. Psychiatry"},{"key":"70534_CR5","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aah5642","author":"ME Ward","year":"2017","unstructured":"Ward, M. E. et al. Individuals with progranulin haploinsufficiency exhibit features of neuronal ceroid lipofuscinosis. Sci. Transl. Med.\nhttps:\/\/doi.org\/10.1126\/scitranslmed.aah5642 (2017).","journal-title":"Sci. Transl. Med."},{"key":"70534_CR6","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1016\/j.biocel.2003.08.009","volume":"36","author":"A Terman","year":"2004","unstructured":"Terman, A. & Brunk, U. T. Lipofuscin. Int. J. Biochem. Cell Biol.36, 1400\u20131404. https:\/\/doi.org\/10.1016\/j.biocel.2003.08.009 (2004).","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"70534_CR7","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1186\/1742-2094-8-65","volume":"8","author":"P Bossu","year":"2011","unstructured":"Bossu, P. et al. Loss of function mutations in the progranulin gene are related to pro-inflammatory cytokine dysregulation in frontotemporal lobar degeneration patients. J. Neuroinflamm.8, 65. https:\/\/doi.org\/10.1186\/1742-2094-8-65 (2011).","journal-title":"J. Neuroinflamm."},{"issue":"1603","key":"70534_CR8","doi-asserted-by":"publisher","first-page":"e1601","DOI":"10.1016\/j.neurobiolaging.2014.10.023","volume":"36","author":"L Gibbons","year":"2015","unstructured":"Gibbons, L. et al. Plasma levels of progranulin and interleukin-6 in frontotemporal lobar degeneration. Neurobiol. Aging36(1603), e1601-1604. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2014.10.023 (2015).","journal-title":"Neurobiol. Aging"},{"key":"70534_CR9","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.bbi.2015.05.006","volume":"49","author":"D Galimberti","year":"2015","unstructured":"Galimberti, D. et al. Inflammatory molecules in Frontotemporal Dementia: cerebrospinal fluid signature of progranulin mutation carriers. Brain Behav. Immun.49, 182\u2013187. https:\/\/doi.org\/10.1016\/j.bbi.2015.05.006 (2015).","journal-title":"Brain Behav. Immun."},{"key":"70534_CR10","doi-asserted-by":"publisher","first-page":"5029","DOI":"10.1073\/pnas.1700477114","volume":"114","author":"G Krabbe","year":"2017","unstructured":"Krabbe, G. et al. Microglial NFkappaB-TNFalpha hyperactivation induces obsessive-compulsive behavior in mouse models of progranulin-deficient frontotemporal dementia. Proc. Natl. Acad. Sci. USA114, 5029\u20135034. https:\/\/doi.org\/10.1073\/pnas.1700477114 (2017).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"70534_CR11","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1002\/glia.22988","volume":"64","author":"PD Wes","year":"2016","unstructured":"Wes, P. D., Sayed, F. A., Bard, F. & Gan, L. Targeting microglia for the treatment of Alzheimer\u2019s disease. Glia64, 1710\u20131732. https:\/\/doi.org\/10.1002\/glia.22988 (2016).","journal-title":"Glia"},{"key":"70534_CR12","doi-asserted-by":"publisher","first-page":"3240","DOI":"10.1172\/JCI90606","volume":"127","author":"H Sarlus","year":"2017","unstructured":"Sarlus, H. & Heneka, M. T. Microglia in Alzheimer\u2019s disease. J. Clin. Invest.127, 3240\u20133249. https:\/\/doi.org\/10.1172\/JCI90606 (2017).","journal-title":"J. Clin. Invest."},{"key":"70534_CR13","doi-asserted-by":"publisher","first-page":"e3000134","DOI":"10.1371\/journal.pbio.3000134","volume":"17","author":"L Zhan","year":"2019","unstructured":"Zhan, L. et al. Proximal recolonization by self-renewing microglia re-establishes microglial homeostasis in the adult mouse brain. PLoS Biol.17, e3000134. https:\/\/doi.org\/10.1371\/journal.pbio.3000134 (2019).","journal-title":"PLoS Biol."},{"key":"70534_CR14","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1016\/j.cell.2016.04.001","volume":"165","author":"H Lui","year":"2016","unstructured":"Lui, H. et al. Progranulin deficiency promotes circuit-specific synaptic pruning by microglia via complement activation. Cell165, 921\u2013935. https:\/\/doi.org\/10.1016\/j.cell.2016.04.001 (2016).","journal-title":"Cell"},{"key":"70534_CR15","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1016\/j.cell.2017.05.018","volume":"169","author":"H Keren-Shaul","year":"2017","unstructured":"Keren-Shaul, H. et al. A Unique microglia type associated with restricting development of Alzheimer\u2019s disease. Cell169, 1276\u20131290. https:\/\/doi.org\/10.1016\/j.cell.2017.05.018 (2017).","journal-title":"Cell"},{"key":"70534_CR16","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1002\/0471142727.mb0413s98","volume":"98","author":"H Li","year":"2012","unstructured":"Li, H., Qiu, J. & Fu, X. D. RASL-seq for massively parallel and quantitative analysis of gene expression. Curr. Protoc. Mol. Biol.98, 4\u201313. https:\/\/doi.org\/10.1002\/0471142727.mb0413s98 (2012).","journal-title":"Curr. Protoc. Mol. Biol."},{"key":"70534_CR17","doi-asserted-by":"publisher","first-page":"4609","DOI":"10.1073\/pnas.1200305109","volume":"109","author":"H Li","year":"2012","unstructured":"Li, H. et al. Versatile pathway-centric approach based on high-throughput sequencing to anticancer drug discovery. Proc. Natl. Acad. Sci. USA109, 4609\u20134614. https:\/\/doi.org\/10.1073\/pnas.1200305109 (2012).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"70534_CR18","doi-asserted-by":"publisher","first-page":"4529","DOI":"10.1038\/s41598-019-39016-5","volume":"9","author":"JM Simon","year":"2019","unstructured":"Simon, J. M., Paranjape, S. R., Wolter, J. M., Salazar, G. & Zylka, M. J. High-throughput screening and classification of chemicals and their effects on neuronal gene expression using RASL-seq. Sci. Rep.9, 4529. https:\/\/doi.org\/10.1038\/s41598-019-39016-5 (2019).","journal-title":"Sci. Rep."},{"key":"70534_CR19","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1016\/j.molmed.2017.08.004","volume":"23","author":"E Wauters","year":"2017","unstructured":"Wauters, E., Van Mossevelde, S., Van der Zee, J., Cruts, M. & Van Broeckhoven, C. Modifiers of GRN-associated frontotemporal lobar degeneration. Trends Mol. Med.23, 962\u2013979. https:\/\/doi.org\/10.1016\/j.molmed.2017.08.004 (2017).","journal-title":"Trends Mol. Med."},{"key":"70534_CR20","doi-asserted-by":"publisher","first-page":"1447","DOI":"10.1093\/brain\/awx060","volume":"140","author":"AE Arrant","year":"2017","unstructured":"Arrant, A. E., Filiano, A. J., Unger, D. E., Young, A. H. & Roberson, E. D. Restoring neuronal progranulin reverses deficits in a mouse model of frontotemporal dementia. Brain140, 1447\u20131465. https:\/\/doi.org\/10.1093\/brain\/awx060 (2017).","journal-title":"Brain"},{"key":"70534_CR21","doi-asserted-by":"publisher","first-page":"2341","DOI":"10.1523\/JNEUROSCI.3081-17.2018","volume":"38","author":"AE Arrant","year":"2018","unstructured":"Arrant, A. E., Onyilo, V. C., Unger, D. E. & Roberson, E. D. Progranulin gene therapy improves lysosomal dysfunction and microglial pathology associated with frontotemporal dementia and neuronal ceroid lipofuscinosis. J. Neurosci.38, 2341\u20132358. https:\/\/doi.org\/10.1523\/JNEUROSCI.3081-17.2018 (2018).","journal-title":"J. Neurosci."},{"key":"70534_CR22","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.ymthe.2018.11.013","volume":"27","author":"DA Amado","year":"2019","unstructured":"Amado, D. A. et al. AAV-mediated progranulin delivery to a mouse model of progranulin deficiency causes T cell-mediated toxicity. Mol. Ther.27, 465\u2013478. https:\/\/doi.org\/10.1016\/j.ymthe.2018.11.013 (2019).","journal-title":"Mol. Ther."},{"key":"70534_CR23","doi-asserted-by":"publisher","first-page":"16101","DOI":"10.1074\/jbc.M110.193433","volume":"286","author":"B Cenik","year":"2011","unstructured":"Cenik, B. et al. Suberoylanilide hydroxamic acid (vorinostat) up-regulates progranulin transcription: rational therapeutic approach to frontotemporal dementia. J. Biol. Chem.286, 16101\u201316108. https:\/\/doi.org\/10.1074\/jbc.M110.193433 (2011).","journal-title":"J. Biol. Chem."},{"key":"70534_CR24","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.neurobiolaging.2016.03.001","volume":"42","author":"S Almeida","year":"2016","unstructured":"Almeida, S., Gao, F., Coppola, G. & Gao, F. B. Suberoylanilide hydroxamic acid increases progranulin production in iPSC-derived cortical neurons of frontotemporal dementia patients. Neurobiol. Aging42, 35\u201340. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2016.03.001 (2016).","journal-title":"Neurobiol. Aging"},{"key":"70534_CR25","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1186\/s13024-016-0114-3","volume":"11","author":"CJ Holler","year":"2016","unstructured":"Holler, C. J. et al. Trehalose upregulates progranulin expression in human and mouse models of GRN haploinsufficiency: a novel therapeutic lead to treat frontotemporal dementia. Mol. Neurodegener.11, 46. https:\/\/doi.org\/10.1186\/s13024-016-0114-3 (2016).","journal-title":"Mol. Neurodegener."},{"key":"70534_CR26","first-page":"5590","volume":"62","author":"Z He","year":"2002","unstructured":"He, Z., Ismail, A., Kriazhev, L., Sadvakassova, G. & Bateman, A. Progranulin (PC-cell-derived growth factor\/acrogranin) regulates invasion and cell survival. Can. Res.62, 5590\u20135596 (2002).","journal-title":"Can. Res."},{"key":"70534_CR27","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1038\/nn.3554","volume":"16","author":"SE Hickman","year":"2013","unstructured":"Hickman, S. E. et al. The microglial sensome revealed by direct RNA sequencing. Nat. Neurosci.16, 1896\u20131905. https:\/\/doi.org\/10.1038\/nn.3554 (2013).","journal-title":"Nat. Neurosci."},{"key":"70534_CR28","doi-asserted-by":"publisher","first-page":"14726","DOI":"10.1021\/ja4056068","volume":"135","author":"M Verdoes","year":"2013","unstructured":"Verdoes, M. et al. Improved quenched fluorescent probe for imaging of cysteine cathepsin activity. J. Am. Chem. Soc.135, 14726\u201314730. https:\/\/doi.org\/10.1021\/ja4056068 (2013).","journal-title":"J. Am. Chem. Soc."},{"key":"70534_CR29","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1042\/bj1860385","volume":"186","author":"E Shaw","year":"1980","unstructured":"Shaw, E. & Dean, R. T. The inhibition of macrophage protein turnover by a selective inhibitor of thiol proteinases. Biochem. J.186, 385\u2013390. https:\/\/doi.org\/10.1042\/bj1860385 (1980).","journal-title":"Biochem. J."},{"key":"70534_CR30","doi-asserted-by":"publisher","first-page":"e20501","DOI":"10.1371\/journal.pone.0020501","volume":"6","author":"D Butler","year":"2011","unstructured":"Butler, D. et al. Protective effects of positive lysosomal modulation in Alzheimer\u2019s disease transgenic mouse models. PLoS ONE6, e20501. https:\/\/doi.org\/10.1371\/journal.pone.0020501 (2011).","journal-title":"PLoS ONE"},{"key":"70534_CR31","doi-asserted-by":"publisher","first-page":"4861","DOI":"10.1093\/hmg\/ddx364","volume":"26","author":"C Valdez","year":"2017","unstructured":"Valdez, C. et al. Progranulin-mediated deficiency of cathepsin D results in FTD and NCL-like phenotypes in neurons derived from FTD patients. Hum. Mol. Genet.26, 4861\u20134872. https:\/\/doi.org\/10.1093\/hmg\/ddx364 (2017).","journal-title":"Hum. Mol. Genet."},{"key":"70534_CR32","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1084\/jem.20091568","volume":"207","author":"F Yin","year":"2010","unstructured":"Yin, F. et al. Exaggerated inflammation, impaired host defense, and neuropathology in progranulin-deficient mice. J. Exp. Med.207, 117\u2013128. https:\/\/doi.org\/10.1084\/jem.20091568 (2010).","journal-title":"J. Exp. Med."},{"key":"70534_CR33","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s13024-018-0281-5","volume":"13","author":"JK Gotzl","year":"2018","unstructured":"Gotzl, J. K. et al. Early lysosomal maturation deficits in microglia triggers enhanced lysosomal activity in other brain cells of progranulin knockout mice. Mol. Neurodegener.13, 48. https:\/\/doi.org\/10.1186\/s13024-018-0281-5 (2018).","journal-title":"Mol. Neurodegener."},{"key":"70534_CR34","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1038\/nrd.2018.65","volume":"17","author":"A Mullard","year":"2018","unstructured":"Mullard, A. Microglia-targeted candidates push the Alzheimer drug envelope. Nat. Rev. Drug Discov.17, 303\u2013305. https:\/\/doi.org\/10.1038\/nrd.2018.65 (2018).","journal-title":"Nat. Rev. Drug Discov."},{"key":"70534_CR35","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.celrep.2017.09.039","volume":"21","author":"H Mathys","year":"2017","unstructured":"Mathys, H. et al. Temporal tracking of microglia activation in neurodegeneration at single-cell resolution. Cell Rep.21, 366\u2013380. https:\/\/doi.org\/10.1016\/j.celrep.2017.09.039 (2017).","journal-title":"Cell Rep."},{"key":"70534_CR36","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s004010050665","volume":"94","author":"Z Nagy","year":"1997","unstructured":"Nagy, Z., Esiri, M. M., Cato, A. M. & Smith, A. D. Cell cycle markers in the hippocampus in Alzheimer\u2019s disease. Acta Neuropathol.94, 6\u201315. https:\/\/doi.org\/10.1007\/s004010050665 (1997).","journal-title":"Acta Neuropathol."},{"key":"70534_CR37","doi-asserted-by":"publisher","first-page":"429-e7","DOI":"10.1016\/j.neurobiolaging.2010.11.020","volume":"33","author":"C Alquezar","year":"2012","unstructured":"Alquezar, C. et al. Alteration in cell cycle-related proteins in lymphoblasts from carriers of the c.709\u20131G>A PGRN mutation associated with FTLD-TDP dementia. Neurobiol. Aging33, 429-e7. https:\/\/doi.org\/10.1016\/j.neurobiolaging.2010.11.020 (2012).","journal-title":"Neurobiol. Aging"},{"key":"70534_CR38","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1007\/s00109-003-0474-3","volume":"81","author":"Z He","year":"2003","unstructured":"He, Z. & Bateman, A. Progranulin (granulin-epithelin precursor, PC-cell-derived growth factor, acrogranin) mediates tissue repair and tumorigenesis. J. Mol. Med. (Berl.)81, 600\u2013612. https:\/\/doi.org\/10.1007\/s00109-003-0474-3 (2003).","journal-title":"J. Mol. Med. (Berl.)"},{"key":"70534_CR39","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1021\/jm00385a002","volume":"30","author":"PS Portoghese","year":"1987","unstructured":"Portoghese, P. S., Lipkowski, A. W. & Takemori, A. E. Bimorphinans as highly selective, potent kappa opioid receptor antagonists. J. Med. Chem.30, 238\u2013239. https:\/\/doi.org\/10.1021\/jm00385a002 (1987).","journal-title":"J. Med. Chem."},{"key":"70534_CR40","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1021\/jm00399a026","volume":"31","author":"PS Portoghese","year":"1988","unstructured":"Portoghese, P. S., Nagase, H., Lipkowski, A. W., Larson, D. L. & Takemori, A. E. Binaltorphimine-related bivalent ligands and their kappa opioid receptor antagonist selectivity. J. Med. Chem.31, 836\u2013841. https:\/\/doi.org\/10.1021\/jm00399a026 (1988).","journal-title":"J. Med. Chem."},{"key":"70534_CR41","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1523\/JNEUROSCI.4458-07.2008","volume":"28","author":"BB Land","year":"2008","unstructured":"Land, B. B. et al. The dysphoric component of stress is encoded by activation of the dynorphin kappa-opioid system. J. Neurosci.28, 407\u2013414. https:\/\/doi.org\/10.1523\/JNEUROSCI.4458-07.2008 (2008).","journal-title":"J. Neurosci."},{"key":"70534_CR42","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1111\/j.1471-4159.2004.02589.x","volume":"90","author":"Y Shirayama","year":"2004","unstructured":"Shirayama, Y. et al. Stress increases dynorphin immunoreactivity in limbic brain regions and dynorphin antagonism produces antidepressant-like effects. J. Neurochem.90, 1258\u20131268. https:\/\/doi.org\/10.1111\/j.1471-4159.2004.02589.x (2004).","journal-title":"J. Neurochem."},{"key":"70534_CR43","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.ejphar.2007.05.045","volume":"570","author":"H Zhang","year":"2007","unstructured":"Zhang, H., Shi, Y. G., Woods, J. H., Watson, S. J. & Ko, M. C. Central kappa-opioid receptor-mediated antidepressant-like effects of nor-Binaltorphimine: behavioral and BDNF mRNA expression studies. Eur. J. Pharmacol.570, 89\u201396. https:\/\/doi.org\/10.1016\/j.ejphar.2007.05.045 (2007).","journal-title":"Eur. J. Pharmacol."},{"key":"70534_CR44","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1111\/adb.12206","volume":"21","author":"BA Hutsell","year":"2016","unstructured":"Hutsell, B. A., Cheng, K., Rice, K. C., Negus, S. S. & Banks, M. L. Effects of the kappa opioid receptor antagonist nor-binaltorphimine (nor-BNI) on cocaine versus food choice and extended-access cocaine intake in rhesus monkeys. Addict. Biol.21, 360\u2013373. https:\/\/doi.org\/10.1111\/adb.12206 (2016).","journal-title":"Addict. Biol."},{"key":"70534_CR45","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.bbr.2015.01.008","volume":"283","author":"JE Kelsey","year":"2015","unstructured":"Kelsey, J. E., Verhaak, A. M. & Schierberl, K. C. The kappa-opioid receptor antagonist, nor-binaltorphimine (nor-BNI), decreases morphine withdrawal and the consequent conditioned place aversion in rats. Behav. Brain. Res.283, 16\u201321. https:\/\/doi.org\/10.1016\/j.bbr.2015.01.008 (2015).","journal-title":"Behav. Brain. Res."},{"key":"70534_CR46","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/s0163-7258(00)00051-6","volume":"87","author":"F Schwede","year":"2000","unstructured":"Schwede, F., Maronde, E., Genieser, H.-G. & Jastorff, B. Cyclic nucleotide analogs as biochemical tools and prospective drugs. Pharmacol. Ther.87, 199\u2013226. https:\/\/doi.org\/10.1016\/s0163-7258(00)00051-6 (2000).","journal-title":"Pharmacol. Ther."},{"key":"70534_CR47","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1146\/annurev.bi.44.070175.002423","volume":"44","author":"IH Pastan","year":"1975","unstructured":"Pastan, I. H., Johnson, G. S. & Anderson, W. B. Role of cyclic nucleotides in growth control. Annu. Rev. Biochem.44, 491\u2013522. https:\/\/doi.org\/10.1146\/annurev.bi.44.070175.002423 (1975).","journal-title":"Annu. Rev. Biochem."},{"key":"70534_CR48","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/0014-5793(73)80367-9","volume":"36","author":"B Hamprecht","year":"1973","unstructured":"Hamprecht, B., Jaffe, B. M. & Philpott, G. W. Prostaglandin production by neuroblastoma, glioma and fibroblast cell lines; stimulation by N6, O2\u2032-dibutyryl adenosine 3\u2032:5\u2032-cyclic monophosphate. FEBS Lett.36, 193\u2013198. https:\/\/doi.org\/10.1016\/0014-5793(73)80367-9 (1973).","journal-title":"FEBS Lett."},{"key":"70534_CR49","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.neulet.2003.11.056","volume":"356","author":"M-S Woo","year":"2004","unstructured":"Woo, M.-S., Jung, S.-H., Hyun, J.-W. & Kim, H.-S. Differential regulation of inducible nitric oxide synthase and cytokine gene expression by forskolin and dibutyryl-cAMP in lipopolysaccharide-stimulated murine BV2 microglial cells. Neurosci. Lett.356, 187\u2013190. https:\/\/doi.org\/10.1016\/j.neulet.2003.11.056 (2004).","journal-title":"Neurosci. Lett."},{"key":"70534_CR50","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1007\/s00436-008-1300-1","volume":"104","author":"A Talvani","year":"2009","unstructured":"Talvani, A., Coutinho, S. F., Barcelos Lda, S. & Teixeira, M. M. Cyclic AMP decreases the production of NO and CCL2 by macrophages stimulated with Trypanosoma cruzi GPI-mucins. Parasitol. Res.104, 1141\u20131148. https:\/\/doi.org\/10.1007\/s00436-008-1300-1 (2009).","journal-title":"Parasitol. Res."},{"key":"70534_CR51","doi-asserted-by":"publisher","first-page":"51","DOI":"10.3389\/fonc.2017.00051","volume":"7","author":"SG Mathiassen","year":"2017","unstructured":"Mathiassen, S. G., De Zio, D. & Cecconi, F. Autophagy and the cell cycle: a complex landscape. Front Oncol.7, 51. https:\/\/doi.org\/10.3389\/fonc.2017.00051 (2017).","journal-title":"Front Oncol."},{"key":"70534_CR52","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1016\/j.cell.2013.11.019","volume":"155","author":"JY Guo","year":"2013","unstructured":"Guo, J. Y., Xia, B. & White, E. Autophagy-mediated tumor promotion. Cell155, 1216\u20131219. https:\/\/doi.org\/10.1016\/j.cell.2013.11.019 (2013).","journal-title":"Cell"},{"key":"70534_CR53","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1016\/j.jmb.2019.01.027","volume":"431","author":"VJ Butler","year":"2019","unstructured":"Butler, V. J. et al. Progranulin stimulates the in vitro maturation of pro-cathepsin D at acidic pH. J. Mol. Biol.431, 1038\u20131047. https:\/\/doi.org\/10.1016\/j.jmb.2019.01.027 (2019).","journal-title":"J. Mol. Biol."},{"key":"70534_CR54","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1093\/hmg\/ddx011","volume":"26","author":"Y Tanaka","year":"2017","unstructured":"Tanaka, Y. et al. Progranulin regulates lysosomal function and biogenesis through acidification of lysosomes. Hum. Mol. Genet.26, 969\u2013988. https:\/\/doi.org\/10.1093\/hmg\/ddx011 (2017).","journal-title":"Hum. Mol. Genet."},{"key":"70534_CR55","doi-asserted-by":"publisher","first-page":"3955","DOI":"10.1172\/JCI63113","volume":"122","author":"LH Martens","year":"2012","unstructured":"Martens, L. H. et al. Progranulin deficiency promotes neuroinflammation and neuron loss following toxin-induced injury. J. Clin. Invest.122, 3955\u20133959. https:\/\/doi.org\/10.1172\/JCI63113 (2012).","journal-title":"J. Clin. Invest."},{"key":"70534_CR56","unstructured":"R: A Language and Environment for Statistical Computing (R Foundation for Statistical Computing, Vienna, Austria, 2017)."},{"key":"70534_CR57","unstructured":"Rasband, W. S. ImageJ. (U. S. National Institutes of Health, 1997\u20132018)."},{"key":"70534_CR58","doi-asserted-by":"publisher","first-page":"896","DOI":"10.1038\/nbt.2931","volume":"32","author":"D Risso","year":"2014","unstructured":"Risso, D., Ngai, J., Speed, T. P. & Dudoit, S. Normalization of RNA-seq data using factor analysis of control genes or samples. Nat. Biotechnol.32, 896\u2013902. https:\/\/doi.org\/10.1038\/nbt.2931 (2014).","journal-title":"Nat. Biotechnol."},{"key":"70534_CR59","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol.15, 550. https:\/\/doi.org\/10.1186\/s13059-014-0550-8 (2014).","journal-title":"Genome Biol."},{"key":"70534_CR60","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/ng1180","volume":"34","author":"VK Mootha","year":"2003","unstructured":"Mootha, V. K. et al. PGC-1\u03b1-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat. Genet.34, 267\u2013273. https:\/\/doi.org\/10.1038\/ng1180 (2003).","journal-title":"Nat. Genet."},{"key":"70534_CR61","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian, A. et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci USA102, 15545\u201315550. https:\/\/doi.org\/10.1073\/pnas.0506580102 (2005).","journal-title":"Proc. Natl. Acad. Sci USA"},{"key":"70534_CR62","doi-asserted-by":"publisher","first-page":"D447","DOI":"10.1093\/nar\/gku1003","volume":"43","author":"D Szklarczyk","year":"2015","unstructured":"Szklarczyk, D. et al. STRING v10: protein-protein interaction networks, integrated over the tree of life. Nucleic Acids Res.43, D447-452. https:\/\/doi.org\/10.1093\/nar\/gku1003 (2015).","journal-title":"Nucleic Acids Res."},{"key":"70534_CR63","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1101\/gr.1239303","volume":"13","author":"P Shannon","year":"2003","unstructured":"Shannon, P. et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res13, 2498\u20132504. https:\/\/doi.org\/10.1101\/gr.1239303 (2003).","journal-title":"Genome Res"},{"key":"70534_CR64","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","volume":"1","author":"A Liberzon","year":"2015","unstructured":"Liberzon, A. et al. The Molecular Signatures Database (MSigDB) hallmark gene set collection. Cell Syst.1, 417\u2013425. https:\/\/doi.org\/10.1016\/j.cels.2015.12.004 (2015).","journal-title":"Cell Syst."},{"key":"70534_CR65","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/75556","volume":"25","author":"M Ashburner","year":"2000","unstructured":"Ashburner, M. et al. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat. Genet.25, 25\u201329. https:\/\/doi.org\/10.1038\/75556 (2000).","journal-title":"Nat. Genet."},{"key":"70534_CR66","doi-asserted-by":"publisher","first-page":"D330","DOI":"10.1093\/nar\/gky1055","volume":"47","author":"The Gene Ontology Consortium","year":"2019","unstructured":"The Gene Ontology Consortium. The Gene Ontology Resource: 20 years and still GOing strong. Nucleic Acids Res.47, D330\u2013D338. https:\/\/doi.org\/10.1093\/nar\/gky1055 (2019).","journal-title":"Nucleic Acids Res."},{"key":"70534_CR67","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.201901097","author":"DP Narendra","year":"2020","unstructured":"Narendra, D. P. et al. Coupling APEX labeling to imaging mass spectrometry of single organelles reveals heterogeneity in lysosomal protein turnover. J. Cell Biol.\nhttps:\/\/doi.org\/10.1083\/jcb.201901097 (2020).","journal-title":"J. Cell Biol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-70534-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-70534-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-70534-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T12:07:05Z","timestamp":1670328425000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-70534-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8,13]]},"references-count":67,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["70534"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-70534-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,8,13]]},"assertion":[{"value":"7 January 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 July 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"L.G. is a founder of Aeton Therapeutics, Inc. B.A.B is co-inventor on U.S. Patent 8,163,953 and has patent applications pending regarding materials and compound combinations for cathepsin B modulation and methods of use for treating Alzheimer\u2019s disease, mild cognitive impairment, and early dementia. All other authors (M.A.T., K.L, F.A.S, J.I.E, M.X., L.Z, Y.L., Y.Z., D.L., M.B., and S.D.) declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"13688"}}